Methods for reducing complexity of a sample using small epitope antibodies

a technology of epitope antibodies and small sample sizes, applied in the field of methods for can solve the problems of large sample sizes, time-consuming, and limited in the ability to reproduce a significant fraction, and achieve the effect of reducing the complexity of samples

Inactive Publication Date: 2005-06-16
TETHYS BIOSCI
View PDF42 Cites 35 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0007] In one aspect, the invention provides methods for reducing the complexity of a sample, said methods comprising: (a) contacting a sample with one or more small epitope antibody under conditions that permit binding; and (b) separating an antibody-protein complex, whereby proteins comprising one or more epitope(s) bound by the one or more small epitope antibody are isolated, separated, enriched and / or purified.

Problems solved by technology

This 2D-gel technique requires large sample sizes, is time consuming, and is currently limited in its ability to reproducibly resolve a significant fraction of the proteins expressed by a human cell.
Techniques involving some large-format 2D-gels can produce gels which separate a larger number of proteins than traditional 2D-gel techniques, but reproducibility is still poor and over 95% of the spots cannot be sequenced due to limitations with respect to sensitivity of the available sequencing techniques.
The electrophoretic techniques are also plagued by a bias towards proteins of high abundance.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods for reducing complexity of a sample using small epitope antibodies
  • Methods for reducing complexity of a sample using small epitope antibodies
  • Methods for reducing complexity of a sample using small epitope antibodies

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation and Characterization of Small Epitope Antibodies

[0198] Five immunization polypeptides in the format of Multiple Antigenic Peptide (MAP) were designed as shown in Table 3. These sequences in combination were also used to evaluate cross-reactivity of the induced antibodies, by virtue of the inclusion in different MAPs of the same sequence in differing locations. Each of the immunization polypeptides was used to immunize 4 Balb / C mice using standard methods.

TABLE 3Design of immunization polypeptidesPeptideGroupSequenceSEQ ID NOMAP11MAP22MAP33MAP44MAP55

Notes to Table 3:

Polypeptide MAP1: HSLFHPEDTGQV: From PSA, amino acids #79-89. KKTTNV: From Meningococcal Opa protein, containing KTT, a published 3mer antibody epitope (Malorny, Morelli et al. 1998).

Polypeptide MAP2: Alternate sequences of MAP 1.

Polypeptide MAP3: LTPKK: Motif 1 of PSA (Nagasaki, Watanabe et al. 1999). KKTTNVLTVPTNIPG: From Meningococcal Opa protein, containing two published 3mer antibody epitopes: KTT a...

example 2

Preparation of Small Epitope Antibodies

[0213] An approach to identify antibodies based on phage display antibody screening was performed. Five peptide sequences used for the selection of positive antibodies are shown in Table 9. These sequences in combination were also used to evaluate cross-reactivity of the selected antibodies.

TABLE 9Design of screening polypeptidesPeptideSequenceP1CXXXXXDTGXXXXXXP6CXXXXXDTGXXXXXXP7CXXXXXAQVXXXXXXP8CXXXXXIARXXXXXXP9CXXXXXLSHXXXXXX

[0214] Note to Table 9: The letter ‘X’ denotes a mixture of the naturally-occurring L-amino acids excluding cysteine, methionine, and tryptophan.

[0215] Positives were selected after six rounds of enrichment. The results of phage ELISA screens against the five screening peptides is shown in Table 10. A total of 96 phage were screened for P1; 48 were screened for polypeptides P6-P9. In all cases, positive phage were identified above background.

TABLE 10Reactivity of enriched phage against screening polypeptidesPolypept...

example 3

Protein Profiling and Biomarker Development

[0218] In one exemplary method for protein profiling, serums derived from healthy and affected individuals for a particular disease of clinical interest are subjected to: (a) debulking of the most abundant protein constituents; (b) deglycosylation of the less abundant proteins that remain; (c) reduction and alkylation of cysteine residues present in the debulked proteome; (d) digestion of the debulked proteome to completion; (e) fractionation of the resulting peptide fragments with small epitope antibodies as described above; and (f) comparison of the composition and relative abundance of peptide constituents from epitope enriched fractions derived from healthy and affected patients to identify candidate biomarkers associated with a specific disease.

[0219] Fractionation with small epitope antibodies is performed in parallel with a set of approximately 100 small epitope antibodies of different specificities. Each antibody is chosen based o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
chemicalaaaaaaaaaa
mass spectrometryaaaaaaaaaa
structureaaaaaaaaaa
Login to view more

Abstract

The present invention relates generally to methods for reducing the complexity of a sample. More specifically, the present invention relates to proteomics, the measurement of the protein levels in biological samples, and analysis of proteins in a sample using antibodies that recognize small epitopes.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] This application claims the benefit of U.S. Provisional Application No. 60 / 496,154, filed on Aug. 18, 2003, and 60 / 511,720, filed on Oct. 15, 2003, which are hereby incorporated by reference in their entireties.FIELD OF THE INVENTION [0002] The present invention relates generally to methods for reducing the complexity of a sample. More specifically, the present invention relates to proteomics, the measurement of the protein levels in biological samples, and analysis of proteins in a sample using antibodies that recognize small epitopes. BACKGROUND OF THE INVENTION [0003] Proteomics offers a more direct look at the biological functions of a cell or organism than does genomics, the traditional focus for evaluation of gene activity. Proteomics involves the qualitative and quantitative measurement of gene activity by detecting and quantitating expression at the protein level, rather than at the messenger RNA level. Proteomics also involves ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A23J1/00C07K1/00C07K14/00C07K16/00C07K17/00C12Q1/68G01N33/68
CPCG01N33/6803Y10T436/10G01N2800/52G01N33/6848
Inventor URDEA, MICHAELLANDES, GREGORYWENT, GREGORY
Owner TETHYS BIOSCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap